Objective: In the Netherlands, the majority of hereditary head and neck paragangliomas (HNPGL) are caused by germline variants in the succinate dehydrogenase genes (SDHD, SDHB, SDHAF2). Here, we evaluate a four-generation family linked to a novel SDHB gene variant with the manifestation of a HNPGL.
catecholamines in 4%-30% of the cases, which may cause elevated blood pressure, palpitations, flushes and agitation, and may ultimately result in severe cardiovascular complications. [1] [2] [3] Head and neck paragangliomas (HNPGLs) are most commonly found at the carotid bifurcation (60%), but can also arise at the jugular bulb, along the vagal nerve or the tympanic nerve. 4 The closely related pheochromocytoma (PHEO), also known as adrenal PGL, together with the thoracic and abdominal extra-adrenal PGL are paraganglion tumours associated with the sympathetic nervous system.
In about 40% of the patients with an apparently sporadic presentation of PGL or PHEO, a genetic predisposition can be identified. 4 There is considerable genetic heterogeneity in PGL and PHEO, cur- PHEOs and metastatic disease than carriers in the other subunits of the SDH gene. 8 Furthermore, SDHB gene variants are implicated in the development of renal cell carcinoma, papillary thyroid carcinoma and GIST tumours. [8] [9] [10] In this study, we describe the occurrence of HNPGL in a fourgeneration family linked to a novel SDHB gene variant. The index patients are 2 young sisters that did not present themselves with a HNPGL or PHEO, but with a rhabdomyosarcoma and a non-Hodgkin lymphoma. Array-based comparative genomic hybridisation (aCGH) analysis and subsequent multiplex ligation-dependent probe amplification (MLPA) revealed a deletion of exon 1-3 in the SDHB gene in both patients that has not been described previously.
Although SDHB immunostaining of the rhabdomyosarcoma and non-Hodgkin lymphoma showed that there was no causal relationship between the SDHB gene variant and these tumours, this novel exon deletion was suspected to predispose to PGL/PHEO syn- 
Key Points
• A deletion of exon 1-3 in the SDHB gene is associated with the formation of hereditary HNPGL.
• Cascade screening of family members carrying this mutation is important to detect pre-symptomatic PGL. Especially in case of catecholamine-producing tumours, timely intervention may prevent cardiovascular complications.
in SDHB exon 1 and in exon 3 are known to cause hereditary PGL syndrome type 4 and predispose to HNPGL, PHEO, extra-adrenal PGL and malignant PGL/PHEO. [13] [14] [15] Despite the lack of apparent symptomatic neuroendocrine tumours in this family, cascade screening was offered to the family members of these 2 patients.
Subsequently, 18 relatives at risk belonging to a four-generation family with a total of 43 members were tested for this specific SDHB exon deletion. Eight individuals tested negative and were considered not to be at risk of PGL/PHEO formation. Ten family members (6 women, 4 men) were carriers of the deletion of exon 1-3 in the SDHB gene (Figure 1 ). 4 | DISCUSSION
| Synopsis of new findings
In this report, we describe a novel deletion of exon 1-3 in SDHB
causing HNPGL formation. We tested 18 relatives belonging to a four-generation family consisting of 43 members, of whom 10 were identified to carry this novel SDHB germline variant. One patient was diagnosed with an asymptomatic carotid body PGL and serum catecholamine excess. Negative SDHB immunostaining of the tumour tissue confirms the association between this novel SDHB variant and the carotid body PGL. 
